by Thanos Panagiotidis | Dec 10, 2019 | In Silico Modelling, Publications and presentations
AI Advances Healthcare Research Harnessing AI for drug discovery applications will significantly speed the identification of promising drug candidates, believes Matt Segall, CEO at Optibrium. The UK-based firm, together with partners Intellegens and Medicines... by Thanos Panagiotidis | Dec 3, 2019 | News
CAMBRIDGE, UK, 3rd December, 2019 – Intellegens, an artificial intelligence (AI) start-up, and, Optibrium™, leading providers of software and services for drug discovery, today announced joint success in the Open Source Malaria (OSM) global initiative aimed at...
Recent Comments